In the competitive field of Mixed Drugs, companies are constantly innovating to stay ahead. Discover the latest patent opposition trends, top opposing and opposed companies, and the most recent patents getting opposed. Stay informed on the latest developments in Mixed Drugs technology and learn how to protect your intellectual property.

Patent challenges are becoming increasingly common in the Mixed Drugs industry as companies work to protect their innovations in a highly competitive market. These legal battles can significantly impact the development and release of new technologies. Below is a list of the latest patents that have been opposed in the Mixed Drugs industry, offering a snapshot of the ongoing struggles over intellectual property rights. For anyone involved in this industry, understanding these patent disputes is essential for navigating its future.

Patent NumberTitleApplicantOpposition DateOpposition Name

Get alerts on new patent oppositions in the Mixed Drugs industry

EP3628319Methods Of Treating Hepatic Encephalopathy Using RifaximinSALIX PHARMACEUTICALS, LTD.Nov 14, 2024ACCORD HEALTHCARE LTD
EP3628319Methods Of Treating Hepatic Encephalopathy Using RifaximinSALIX PHARMACEUTICALS, LTD.Nov 13, 2024STADA-ARZNEIMITTEL AKTIENGESELLSCHAFT
EP3628319Methods Of Treating Hepatic Encephalopathy Using RifaximinSALIX PHARMACEUTICALS, LTD.Nov 12, 2024TEVA PHARMACEUTICAL INDUSTRIES LTD.
EP3823671Inhibition Of Prc2 Subunits To Treat Eye DisordersFONDATION ASILE DES AVEUGLESNov 7, 2024MAIWALD GMBH
EP3628319Methods Of Treating Hepatic Encephalopathy Using RifaximinSALIX PHARMACEUTICALS, INC.Nov 4, 2024HGF LIMITED
EP3791896Combination Therapy Involving Antibodies Against Claudin 18.2 For Treatment Of CancerTRON - TRANSLATIONALE ONKOLOGIE AN DER UNIVERSITÄTSMEDIZIN DER JOHANNES GUTENBERG- UNIVERSITÄT MAINZ GEMEINNÜTZIGE GMBHOct 10, 2024DR. H. ULRICH DORRIES
EP3791896Combination Therapy Involving Antibodies Against Claudin 18.2 For Treatment Of CancerASTELLAS PHARMA INC.Oct 8, 2024MAIWALD GMBH
EP2849802Treatment Of Amd Using Aav Sflt-1AVALANCHE AUSTRALIA PTY LTD.Sep 19, 2024STRAWMAN LIMITED
EP3509582Solvate Form Of (R)-2-Amino-3-Phenylpropyl CarbamateSK BIOPHARMACEUTICALS CO., LTD.Sep 19, 2024KRAUS & LEDERER PARTGMBB
EP3494972Combinations Of Dolutegravir And Lamivudine For The Treaetment Of Hiv InfectionVIIV HEALTHCARE COMPANYSep 13, 2024ZENTIVA K.S.

To stay ahead in the competitive Mixed Drugs industry, companies are constantly innovating. Here are the top patents facing oppositions in the Mixed Drugs industry. Stay informed on the latest opposition trends and learn how to protect your intellectual property.

Patent NumberGrant DateTitleApplicantTotal Oppositions
EP2478907Apr 14, 2021Methods And Compositions For Treating CancerJANSSEN ONCOLOGY, INC.22
EP3626270Oct 11, 2023New UseNOVARTIS AG16
EP2493466Mar 10, 2021Novel Antitumoral Use Of CabazitaxelAVENTIS PHARMA S.A.13
EP2637664Mar 29, 2017Compositions And Methods Of Treating Pulmonary HypertensionGILEAD SCIENCES, INC.10
EP2981255Sep 14, 2022Therapeutic Uses Of EmpagliflozinBOEHRINGER INGELHEIM INTERNATIONAL GMBH10
EP2766040May 15, 2019Uses For And Article Of Manufacture Including Her2 Dimerization Inhibitor PertuzumabF.HOFFMANN-LA ROCHE AG9
EP3038654Oct 30, 2019New UseNOVARTIS AG9
EP3494972Dec 13, 2023Combinations Of Dolutegravir And Lamivudine For The Treaetment Of Hiv InfectionVIIV HEALTHCARE COMPANY9
EP2350096Dec 11, 2019Methods Of Treating Hepatic EncephalopathySALIX PHARMACEUTICALS, LTD.8
EP2928496Oct 9, 2019Crispr-Based Genome Modification And RegulationSIGMA-ALDRICH CO. LLC8